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Abstract: Lead tetraacetate have been demonstrated to be an efficient, low cost 
and mild reagent for the one pot synthesis of acridine derivatives from a variety of 
1,2-diols. 1,2-Diols are oxidised in situ to aldehydes, which in turn undergo 
reaction with dimedone and ammonium acetate to yield acridine derivatives. The 
attractive features of this process are mild reaction conditions, short reaction times, 
broad functional group tolerance, easy isolation of products and excellent yields.  
Thus, the current method is utilizing 1,2-diols instead of benzaldehydes to 
synthesis acridines derivatives 
Keywords: Acridine, lead tetraacetate, multicomponent reaction, 1,2-diols, 
dimedone, acetic acid, ammonium acetate. 
Introduction  
The multi-component reaction (MCR) is one pot process in which at least 
three or more different reactants react for the synthesis of target molecule. MCRs 
tactics are proclaimed to be economic, cost and time effective attributing its 
properties such as reducing the number of synthetic steps, isolation and 
purification process, energy consumption and waste production. Hence, developing 
new MCRs and improvement of existing MCRs are still important areas of 
research in the current synthetic and medicinal organic chemistry.
1-4
 







































































   The synthesis of acridine derivatives, which contain 1,4-dihydropyridines 
parent nucleus is an important reaction, as these scaffolds are found to be a very 
important core in numerous synthetic, pharmaceutical and a wide variety of 
biologically active compounds.
5-13
 A large number of compounds bearing 1,4-
dihydropyridines have entered preclinical and clinical trials over the last few years. 
Many commercially available drugs (Figure 1) including Nifedipine, Clevidipine, 
Lacidipine and Nisoldipine (calcium channel blocker), Nicardipine, Manidipine 
and Felodipine (antihypertensive compounds), Amlodipine (used in coronary 
artery disease) are derived from 1,4-dihydropyridines core entities.
14
 




















 and antileishmanial agents.
24 
Hence, the synthesis of acridine which contain 1,4-DHP’s has evoked much 
attention, as a result of which a variety of synthetic methodologies have been 
reported. The most important approaches are: (i) one pot cyclocondensation of 
aldehydes with dicarbonyls and ammonium acetate,
25
 (ii) one pot 
cyclocondensation of aldehydes with dicarbonyls and methyl amine,
26 
(iii) one pot 
cyclocondensation of aldehydes with dicarbonyls and ammonium bicarbonate.
27
 In 
the past years, a few methods have described the one-pot multicomponent 






















 and ionic liquid.
38
 However, 
these methods have limitations in terms of the use of excess amounts of expensive 
catalysts, product diversity and yields. Hence, the development of a simple and 
high yielding protocol for the one-pot multicomponent synthesis of acridine 
scaffolds is still warranted. 







































































In continuation of our work on the development of useful synthetic 
methodologies,
39,40
 in this study we report the use of lead tetraacetate as an 
oxidizing agent for the one-pot synthesis of acridine derivatives under mild 
conditions. Lead tetraacetate function as oxidizing agent offering several 
advantages such as high yields and purity, broad functional group tolerance and 
easy work up when compared to traditional reagents. The byproduct lead acetate 
can be removed by oxidation with chlorine gas to give PbCl2. The PbCl2 salt 
formed may be separated by filtration making use of its lower solubility. The lead 
acetate can also be removed by many advanced methods.
41-47
  
Though, lead tetraacetate has been identified as an oxidizing agent,
48
 the 
wider scope and synthetic utility of this reagent in multicomponent reactions has 
not been explored. Here, we report a one pot approach for synthesis of acridine 
derivatives starting from various 1,2-diols, dimedone and ammonium acetate 
without the need for an additional catalyst. The tandem process involves oxidation, 




Results and discussion 
First, the reaction of 1,2-diphenyl-1,2-ethanediol with dimedone and 
ammonium acetate was selected as the model reaction for the optimization of the 
reaction conditions (Scheme 1). It was hypothesized that the careful judgment of 
lead tetraacetate might efficiently oxidizes 1,2-diols into the benzaldehyde 
followed by condensation with dimedone and cyclisation and dehydration with 
ammonium acetate in one pot.  A preliminary examination showed that lead 
tetraacetate in dry ethanol, among several other solvents, effectively oxidized 
followed by acetic acid catalysed condensation, cyclisation and dehydration. Upon 
varying the temperature of the reaction from 40 to 70 
o
C, the best yield of 4a was 







































































obtained at 70 
o
C. Further increase of the temperature neither increased the yield 
nor shortened the reaction time. The time taken to achieve complete conversions 
(monitored by TLC) and the isolated yields are recorded in Table 2. Of all the 
reactions using different quantities of reactant, the best results were obtained using 
a 1: 4: 2.2: 1 ratios of 1,2-diols, dimedone, ammonium acetate and lead tetraacetate 
respectively. When a mixture of 1,2-diphenyl-1,2-ethanediol, dimedone, 
ammonium acetate and lead tetraacetate respectively in  dry ethanol were stirred at 
room temperature and then refluxed at 70 
o
C for 2 h, the fused heterocyclic 
product, 3,3,6,6-teteramethyl-9-phenyl-3,4,6,7-tetrahydroacridine-
1,8(2H,5H,9H,10H)-dione (4a) was obtained in excellent yield (95%). 
The role of the solvent in the synthesis of acridine derivatives was then 
studied and the results are depicted in Table 1. Replacing ethanol by acetonitrile 
gave the product in high yield (entry 3) albeit lower than that obtained in ethanol 
(entry 4). The use of other solvents such as dioxane, acetone, THF and methanol 
afforded the desired product in average yields (70–80%, entries 2, 5, 6 and 7), 
while DCM, DMF and DMSO produced lower yields (entries 1, 8 and 9). The 
optimized conditions were established with a reaction temperature of 70 
o
C and 
time of 2 h in ethanol solvent.  
This remarkable activation in the reaction rate prompted us to explore the 
potential of this protocol for the synthesis of a variety of acridine derivatives and 
the results are summarized in Table 2. All the aforementioned reaction proceeded 
expeditiously and delivered good to excellent product yields. The overall yield 
ranged from 95% for 3,3,6,6-teteramethyl-9-phenyl-3,4,6,7-tetrahydroacridine-
1,8(2H,5H,9H,10H)-dione (4a) (entry 1) to 82% for 9-(2,6-dichlorophenyl)-
3,3,6,6-teteramethyl-3,4,6,7-tetrahydroacridine-1,8(2H,5H,9H,10H)-dione (4n) 
(entry 14).  







































































A probable mechanistic pathway for the formation of acridine derivatives is 
analogous to the established mechanism reported in the literature.
49 
The lead 
tetraacetate oxidizes 1,2-diol to benzaldehyde giving acetic acid which in turn 
would able to acid catalyse condensation between benzaldehyde and dimedone 
gives the chalcone. The chalcone undergoes Michael addition with enamine which 
is formed in situ by the reaction of dimedone with ammonium acetate that yields 
the corresponding acridine via the cyclisation followed by the dehydration. 
 
Conclusion 
We have developed an efficient, one pot strategy for the synthesis of 
acridine derivatives by in situ oxidation of 1,2-diols into benzaldehyde followed by 
the reaction with dimedone and ammonium acetate in excellent yields. Tandem 
nature, mild conditions, simple and convenient work-up are the main advantage of 
this reaction.  This protocol is also applicable to the broad range of substrates. The 
current strategy reduces the number of steps in total synthesis. 
Experimental 
General information. 
The melting points were determined by the open capillary method using an 
electric melting point apparatus and are uncorrected. The IR spectra were recorded 
on a Agilent Cary 630 FT-IR Spectrophotometer. 
1
H NMR and 
13
C NMR spectra 
were recorded on a Bruker 400 MHz spectrometer using CDCl3 as a solvents and 
TMS as an internal standard. The chemical shifts are expressed in δ ppm. The mass 
spectrum was recorded on Thermo LCQ Fleet. The purity of the compounds was 
checked by TLC. The elemental analyses were carried out using an Elemental 
Vario Micro Cube CHNS Rapid Analyzer. All the compounds gave satisfactory 







































































elemental analysis. All reagents were purchased from Sigma-Aldrich. Lead 
tetraacetate is a solid compound. The purity of lead tetraacetate is ≥ 99.99%. 
 
Typical procedure for the synthesis of 3,3,6,6-teteramethyl-9-phenyl-3,4,6,7-
tetrahydroacridine-1,8(2H,5H,9H,10H)-dione(4a). 
Lead tetraacetate (0.44g, 1mmol) was added to a solution of 1,2-
diphenylethane-1,2-diol (0.21g, 1mmol), dimedone (0.56g, 4mmol) and 
ammonium acetate (0.16g, 2.2mmol) in dry ethanol (10 mL) in a round-bottomed 
flask fitted with a reflux condenser and a guard tube. The resulting reaction 
mixture was stirred at room temperature for 5 minutes and heated at 70 
o
C in an oil 
bath for 2 h. The progress of the reaction was monitored by TLC. After completion 
of the reaction, water (10 mL) was added and the reaction mixture was allowed to 
cool to room temperature. The solid was collected by filtration at pump, washed 
with cold ethanol and recrystallised from ethanol to obtain pure product. 
2-(3,3,6,6-Teteramethyl-1,8-dioxo-1,2,3,4,5,6,7,8,9,10-decahydroacridin-9-
yl)benzonitrile (4d) 
A pale brown solid, 329 mg (88% yield). IR (ATR, cm
-1
): 3320 (NH), 2230 (CN), 




H NMR (CDCl3, 400 MHz): δ 11.80 
(s, 1H, NH), 7.48-7.26 (m, 4H, Ar-H), 5.49 (s, 1H, CH), 2.50-2.29 (m, 8H, 4CH2), 
1.23 (s, 6H, 2CH3), 1.10 (s, 6H, 2CH3) ppm. 
13
C NMR (CDCl3, 400 MHz): δ 
196.8, 168.7, 161.7, 157.7, 138.0, 136.7, 136.4, 134.6, 131.7, 130.0, 117.1, 80.0, 
51.2, 41.0, 32.4, 30.5, 29.1, 28.5, 21.6, 21.2, 19.6, 14.6 ppm. ESI-MS: [M+H[ 
375.7. Anal. Calcd for C24H26N2O2: C, 76.98; H, 7.00; N, 7.48; found: C, 76.92; H, 
6.95; N, 7.36%. 









































































A white solid, 391 mg (86% yield). IR (ATR, cm
-1
):  3396 (NH), 1731 (C=O),  




H NMR (CDCl3, 400 MHz): δ 7.36 (s, 1H, NH), 
7.34-6.78 (m, 9H, Ar-H), 5.01 (s, 1H, CH), 4.92 (s, 2H, OCH2), 2.42-2.14 (m, 8H, 
4CH2), 1.07 (s, 6H, 2CH3), 0.96 (s, 6H, 2CH3) ppm. 
13
C NMR (CDCl3, 400 MHz): 
δ 195.6, 157.0, 149.3, 137.9, 132.2, 128.4, 128.2, 127.9, 127.2, 120.4, 111.9, 70.4, 
50.9, 40.5, 32.3, 31.9, 29.5, 27.3 ppm. Anal. Calcd for C30H33NO3: C, 79.09; H, 
7.30; N, 3.07; found: C, 78.99; H, 7.20; N, 3.01%. 
9-(4-Bromo-2-fluorophenyl)-3,3,6,6-teteramethyl-3,4,6,7-tetrahydroacridine-
1,8-(2H,5H,9H,10H)-dione (4k) 
A white solid, 374 mg (84% yield). IR (ATR, cm
-1
): 3298 (NH), 1734 (C=O), 1713 




H NMR (CDCl3, 400 MHz): δ 8.14 (s, 1H, NH), 7.30-
6.93 (m, 3H, Ar-H), 5.01 (s, 1H, CH), 2.43-2.16 (m, 8H, 4CH2), 1.17 (s, 6H, 
2CH3), 0.98 (s, 6H, 2CH3) ppm. 
13
C NMR (CDCl3, 400 MHz): δ 196.2, 157.6, 
155.2, 150.0, 143.9, 130.1, 127.8, 120.3, 120.1, 116.1, 115.9, 112.5, 50.8, 40.6, 
33.3, 32.7, 29.5, 27.1 ppm. Anal. Calcd for C23H25BrFNO2: C, 61.89; H, 5.65; N, 
3.14; found: C, 61.79; H, 5.55; N, 3.11%. 
9-(2-Bromo-6-chlorophenyl)-3,3,6,6-teteramethyl-3,4,6,7-tetrahydroacridine-
1,8-(2H,5H,9H,10H)-dione (4o) 
A white solid, 299 mg (83% yield). IR (ATR, cm
-1
): 3283 (NH), 1739 (C=O), 1721 




H NMR (CDCl3, 400 MHz): δ 8.14 (s, 1H, NH), 7.36-
6.95 (m, 3H, Ar-H), 5.05 (s, 1H, CH), 2.33-2.05 (m, 8H, 4CH2), 1.08 (s, 6H, 
2CH3), 0.97 (s, 6H, 2CH3) ppm. 
13
C NMR (CDCl3, 400 MHz): δ 195.8, 193.1, 
149.2, 133.4, 132.9, 131.9, 128.7, 116.0, 115.7, 112.7, 108.3, 105.0, 63.6, 51.6, 







































































50.7, 50.5, 42.6, 40.8, 33.2, 32.7, 29.6, 28.8, 28.6, 27.2 ppm. Anal. Calcd for 
C23H25BrClNO2: C, 59.69; H, 5.44; N, 3.03; found: C, 59.64; H, 5.39; N, 2.95% 
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Scheme 1.  Synthesis of 3,3,6,6-teteramethyl-9-phenyl-3,4,6,7-tetrahydroacridine-






















































Pb(OAc)2 + 3AcOH+ 3H2O1a 2 3 4a





































































Table 1. Optimization of solvents for the synthesis (4a). 
Entry  Solvents (Dry) Time (h) Yield (%) 
1 CH2Cl2 5.5 41 
2 Dioxane 6.5 72 
3 Acetonitrile 4 90 
4 Ethanol 2 95 
5 Acetone 4.5 70 
6 THF 5 77 
7 Methanol 3.5 80 
8 DMF 5.5 45 
9 DMSO 5.5 52 
 

























































































































































































































































































































































































































































































































































































 Lead tetraacetate is an efficient, low cost and mild reagent for the one pot 
synthesis of acridine derivatives from a variety of 1,2-diols. 1,2-Diols are 
oxidised in situ to aldehydes, which in turn undergo reaction with dimedone and 
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